Manzini S, Pinna C, Busnelli M, Cinquanta P, Rigamonti E, Ganzetti G S, Dellera F, Sala A, Calabresi L, Franceschini G, Parolini C, Chiesa G
Department of Pharmacological and Biomolecular Sciences, Università degli Studi di Milano, Milano, Italy.
Department of Pharmacological and Biomolecular Sciences, Università degli Studi di Milano, Milano, Italy; Institute of Biomedicine and Molecular Immunology, CNR, Palermo, Italy.
Vascul Pharmacol. 2015 Nov;74:114-121. doi: 10.1016/j.vph.2015.08.006. Epub 2015 Aug 5.
Lecithin:cholesterol acyltransferase (LCAT) deficiency is associated with hypoalphalipoproteinemia, generally a predisposing factor for premature coronary heart disease. The evidence of accelerated atherosclerosis in LCAT-deficient subjects is however controversial. In this study, the effect of LCAT deficiency on vascular tone and endothelial function was investigated in LCAT knockout mice, which reproduce the human lipoprotein phenotype. Aortas from wild-type (Lcat(wt)) and LCAT knockout (Lcat(KO)) mice exposed to noradrenaline showed reduced contractility in Lcat(KO) mice (P<0.005), whereas acetylcholine exposure showed a lower NO-dependent relaxation in Lcat(KO) mice (P<0.05). Quantitative PCR and Western blotting analyses suggested an adequate eNOS expression in Lcat(KO) mouse aortas. Real-time PCR analysis indicated increased expression of β2-adrenergic receptors vs wild-type mice. Aorta stimulation with noradrenaline in the presence of propranolol, to abolish the β-mediated relaxation, showed the same contractile response in the two mouse lines. Furthermore, propranolol pretreatment of mouse aortas exposed to L-NAME prevented the difference in responses between Lcat(wt) and Lcat(KO) mice. The results indicate that LCAT deficiency leads to increased β2-adrenergic relaxation and to a consequently decreased NO-mediated vasodilation that can be reversed to guarantee a correct vascular tone. The present study suggests that LCAT deficiency is not associated with an impaired vascular reactivity.
卵磷脂胆固醇酰基转移酶(LCAT)缺乏与低α脂蛋白血症有关,而低α脂蛋白血症通常是早发性冠心病的一个易感因素。然而,LCAT缺乏受试者中动脉粥样硬化加速的证据存在争议。在本研究中,我们在可重现人类脂蛋白表型的LCAT基因敲除小鼠中,研究了LCAT缺乏对血管张力和内皮功能的影响。野生型(Lcat(wt))和LCAT基因敲除(Lcat(KO))小鼠的主动脉在去甲肾上腺素作用下,Lcat(KO)小鼠的收缩性降低(P<0.005),而在乙酰胆碱作用下,Lcat(KO)小鼠的一氧化氮(NO)依赖性舒张作用较低(P<0.05)。定量聚合酶链反应(PCR)和蛋白质免疫印迹分析表明,Lcat(KO)小鼠主动脉中内皮型一氧化氮合酶(eNOS)表达正常。实时PCR分析表明,与野生型小鼠相比,Lcat(KO)小鼠β2-肾上腺素能受体的表达增加。在普萘洛尔存在的情况下,用去甲肾上腺素刺激主动脉以消除β介导的舒张作用,结果显示两种小鼠品系的收缩反应相同。此外,用L-NAME处理小鼠主动脉后再用普萘洛尔预处理,可消除Lcat(wt)和Lcat(KO)小鼠之间的反应差异。结果表明,LCAT缺乏导致β2-肾上腺素能舒张作用增强,进而导致NO介导的血管舒张作用减弱,而这种减弱可被逆转以保证正常的血管张力。本研究表明,LCAT缺乏与血管反应性受损无关。